microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

Carcinogenesis. 2012 Jan;33(1):220-5. doi: 10.1093/carcin/bgr245. Epub 2011 Nov 9.

Abstract

Deregulated microRNAs participate in carcinogenesis and cancer progression, but their roles in cancer development remain unclear. In this study, miR-365 expression was found to be downregulated in human colon cancer tissues as compared with that in matched non-neoplastic mucosa tissues, and its downregulation was correlated with cancer progression and poor survival in colon cancer patients. Functional studies revealed that restoration of miR-365 expression inhibited cell cycle progression, promoted 5-fluorouracil-induced apoptosis and repressed tumorigenicity in colon cancer cell lines. Furthermore, bioinformatic prediction and experimental validation were used to identify miR-365 target genes and indicated that the antitumor effects of miR-365 were probably mediated by its targeting and repression of Cyclin D1 and Bcl-2 expression, thus inhibiting cell cycle progression and promoting apoptosis. These results suggest that downregulation of miR-365 in colon cancer may have potential applications in prognosis prediction and gene therapy in colon cancer patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Cell Cycle
  • Cell Line, Tumor
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / prevention & control
  • Cyclin D1 / genetics*
  • Disease Progression
  • Down-Regulation
  • Female
  • Fluorouracil / pharmacology
  • Genes, bcl-2*
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • MicroRNAs / physiology*

Substances

  • CCND1 protein, human
  • MIRN365 microRNA, human
  • MicroRNAs
  • Cyclin D1
  • Fluorouracil